Brendan Foley is a John F. Kennedy fellow and Master of Public Policy student at the Harvard Kennedy School. Previously, he worked in public affairs at PEPFAR and in global health advocacy advancing U.S. support for the Global Fund to Fight AIDS, Tuberculosis and Malaria. He holds a Bachelor of Arts in Economics and International Relations from Tufts University.
Opinion: Omitting HIV prevention targets from these deals will be devastating to the affordability and scale-up of the drug lenacapavir. African leaders can change that.